Enlightenment of international pharmacovigilance system on establishment of pharmacovigilance system of Chinese medicine.
10.19540/j.cnki.cjcmm.20210918.501
- Author:
Xin CUI
1
;
Lian-Xin WANG
1
;
Guang-Yu LIU
2
;
Yan-Ming XIE
1
Author Information
1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China.
2. Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
European Union;
ICH;
World Health Orgnization(WHO) Uppsala Monitoring Center;
pharmacovigilance system
- MeSH:
Adverse Drug Reaction Reporting Systems;
Books;
Drug-Related Side Effects and Adverse Reactions/epidemiology*;
European Union;
Humans;
Medicine, Chinese Traditional;
Pharmacovigilance
- From:
China Journal of Chinese Materia Medica
2021;46(21):5450-5455
- CountryChina
- Language:Chinese
-
Abstract:
Pharmacovigilance system is an extension of the original adverse drug reactions monitoring and reporting system as well as an internationally recognized basic system that must be matched with the whole life cycle supervision of drugs. European Union(EU)pharmacovigilance system, World Health Orgnization(WHO) Uppsala Monitoring Center system and ICH system are internationally recognized pharmacovigilance systems. They all have their own pharmacovigilance characteristics and could provide guarantee for clinical safe drug use. With the deepening of international communication, pharmacovigilance has also been developed in China. Pharmacovigilance of Chinese medicine is a new concept based on the existing pharmacovigilance system of chemical medicine and the characteristics of Chinese medicine. In ancient China, Chinese medicine also had its own ways of early warning. Ancient medical books have records on the toxicity classification, clinical pharmacovigilance and intoxication rescue of Chinese medicine. With the increase of public recognition of Chinese medicine in recent years, especially since the government issued the 13 th Five-Year Plan for the development of Chinese medicine, the pharmaceutical industry in China has paid more and more attention to the pharmacovigilance of Chinese medicine.However, the pharmacovigilance system of Chinese medicine has not yet been established, and it still needs to be explored and improved.Therefore, it is very necessary to develop the system to standardize pharmacovigilance-related activities of Chinese medicine. In this context, this study analyzed and learned the characteristics of pharmacovigilance systems of EU, ICH, and WHO Uppsala Monitoring Center, so as to provide some enlightenment for the establishment and improvement of pharmacovigilance system of Chinese medicine.
